ReviewAdvances in experimental medicine and biology2026
Ecological Momentary Assessment and Voice-Informed Forecast and Detection for the Diagnosis of Major Depression.
Review in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Major depressive disorder (MDD) is a prevalent and disabling mental health condition traditionally diagnosed through subjective clinical interviews and retrospective self-reports, methods that are limited by recall biases and diagnostic heterogeneity. To address these limitations, ecological momentary assessment (EMA) and voice-based analysis have emerged as innovative diagnostic and monitoring tools. EMA captures real-time, context-rich data in naturalistic settings, providing nuanced insights into the dynamics of depressive symptoms, daily stressors, and coping strategies. Voice analysis leverages quantitative acoustic and linguistic biomarkers, reflecting underlying neurophysiological and psychomotor changes characteristic of depressive episodes. Integrating these technologies offers objective, scalable, and real-time approaches to enhance diagnostic accuracy, personalize interventions, and facilitate continuous patient monitoring. Nevertheless, practical challenges, including technological accessibility, participant adherence, data interpretation complexities, ethical concerns, and the necessity for robust validation, remain critical barriers. Future research directions highlight the need for digital phenotyping strategies using big data analytics to redefine depressive disorders beyond conventional DSM frameworks, ultimately paving the way for precision psychiatry.
Indexed as
Identifiers
42036564What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.